Avadel Pharmaceuticals PLC(AVDL)stock report

Avadel Pharmaceuticals, PLC is a specialty pharmaceutical company. The Company offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. The Company offers its products in various categories, including hospital, including Bloxiverz, Vazculep and Akovaz, and pediatrics, including Karbinal ER, Cefaclor for Oral Suspension, AcipHex Sprinkle and Flexichamber. Bloxiverz is a drug used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Vazculep is used to treat clinically hypotension resulting primarily from vasodilation in the setting of anesthesia. Akovaz is indicated to treat clinically hypotension in the setting of anesthesia. Cefaclor is indicated for the treatment of otitis media, lower respiratory infections, pharyngitis and tonsillitis, urinary tract infections, and skin and skin structure infections, caused by susceptible organisms.

Q3 2019(9/30/19): Cash 72.45M. Loss 8.87M

EPS and Sales:

Date EPS % last year % last quarter
2018.12.31 -2.55 -250.89% 203.57%
2019.3.31 -0.35 -9.38% 86.27%
2019.6.31 -0.58 -38.10% 12.00%
2019.9.30 -0.82 2.38% -41.38%


Date Sales % last year % last quarter
2018.12.31 103M -40.39% 20.05%
2019.3.31 16.44M -50.63% -84.04%
2019.6.31 33.99M -45.63% 106.75%
2019.9.30 48.22M -41.44% 41.87%


Insider Transactions:

Institution Ownership:

Total institutions: 52,no change
Shares hold: 19370.9k shares. no change
shares% hold: 51.72%,no change

Analyst Ratings:

Leave a Reply